These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 31034982)
1. Carbon monoxide (CO)-Strengthened cooperative bioreductive anti-tumor therapy via mitochondrial exhaustion and hypoxia induction. Li Y; Dang J; Liang Q; Yin L Biomaterials; 2019 Jul; 209():138-151. PubMed ID: 31034982 [TBL] [Abstract][Full Text] [Related]
2. Cancer-Selective Bioreductive Chemotherapy Mediated by Dual Hypoxia-Responsive Nanomedicine upon Photodynamic Therapy-Induced Hypoxia Aggravation. Zhu R; He H; Liu Y; Cao D; Yan J; Duan S; Chen Y; Yin L Biomacromolecules; 2019 Jul; 20(7):2649-2656. PubMed ID: 31125209 [TBL] [Abstract][Full Text] [Related]
3. Targeting triple-negative breast cancer with an aptamer-functionalized nanoformulation: a synergistic treatment that combines photodynamic and bioreductive therapies. Chou YT; Lin CY; Wen JW; Hung LC; Chang YF; Yang CM; Wu LC; Ho JA J Nanobiotechnology; 2021 Mar; 19(1):89. PubMed ID: 33781277 [TBL] [Abstract][Full Text] [Related]
4. Stepwise-activatable hypoxia triggered nanocarrier-based photodynamic therapy for effective synergistic bioreductive chemotherapy. Ihsanullah KM; Kumar BN; Zhao Y; Muhammad H; Liu Y; Wang L; Liu H; Jiang W Biomaterials; 2020 Jul; 245():119982. PubMed ID: 32224374 [TBL] [Abstract][Full Text] [Related]
5. Thermal-Responsive Carbon Monoxide (CO) Delivery Expedites Metabolic Exhaustion of Cancer Cells toward Reversal of Chemotherapy Resistance. Li Y; Dang J; Liang Q; Yin L ACS Cent Sci; 2019 Jun; 5(6):1044-1058. PubMed ID: 31263764 [TBL] [Abstract][Full Text] [Related]
6. A photothermal-hypoxia sequentially activatable phase-change nanoagent for mitochondria-targeting tumor synergistic therapy. Qu J; Teng D; Sui G; Guan S; Wang Y; Wang Q; Lin Y; Ran H; Wang Z; Wang H Biomater Sci; 2020 Jun; 8(11):3116-3129. PubMed ID: 32352102 [TBL] [Abstract][Full Text] [Related]
7. H Qiao L; Ou Y; Li L; Wu S; Guo Y; Liu M; Yu D; Chen Q; Yuan J; Wei C; Ou C; Li H; Cheng D; Yu Z; Li Z J Nanobiotechnology; 2024 Apr; 22(1):205. PubMed ID: 38658965 [TBL] [Abstract][Full Text] [Related]
8. Antagonism of buthionine sulfoximine cytotoxicity for human neuroblastoma cell lines by hypoxia is reversed by the bioreductive agent tirapazamine. Yang B; Keshelava N; Anderson CP; Reynolds CP Cancer Res; 2003 Apr; 63(7):1520-6. PubMed ID: 12670899 [TBL] [Abstract][Full Text] [Related]
9. Combinational phototherapy and hypoxia-activated chemotherapy favoring antitumor immune responses. Ma B; Sheng J; Wang P; Jiang Z; Borrathybay E Int J Nanomedicine; 2019; 14():4541-4558. PubMed ID: 31417257 [No Abstract] [Full Text] [Related]
10. Iodinated cyanine dye-based nanosystem for synergistic phototherapy and hypoxia-activated bioreductive therapy. Dong Y; Zhou L; Shen Z; Ma Q; Zhao Y; Sun Y; Cao J Drug Deliv; 2022 Dec; 29(1):238-253. PubMed ID: 35001784 [TBL] [Abstract][Full Text] [Related]
11. Cancer cell membrane-coated biomimetic platform for tumor targeted photodynamic therapy and hypoxia-amplified bioreductive therapy. Li SY; Cheng H; Qiu WX; Zhang L; Wan SS; Zeng JY; Zhang XZ Biomaterials; 2017 Oct; 142():149-161. PubMed ID: 28735175 [TBL] [Abstract][Full Text] [Related]
13. ROS-sensitive biomimetic nanocarriers modulate tumor hypoxia for synergistic photodynamic chemotherapy. Liu H; Jiang W; Wang Q; Hang L; Wang Y; Wang Y Biomater Sci; 2019 Aug; 7(9):3706-3716. PubMed ID: 31187794 [TBL] [Abstract][Full Text] [Related]
14. Light-Decomposable Polymeric Micelles with Hypoxia-Enhanced Phototherapeutic Efficacy for Combating Metastatic Breast Cancer. Li Y; Tong A; Niu P; Guo W; Jin Y; Hu Y; Tao P; Miao W Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35213986 [TBL] [Abstract][Full Text] [Related]
15. Near-infrared light triggered liposomes combining photodynamic and chemotherapy for synergistic breast tumor therapy. Yang Y; Yang X; Li H; Li C; Ding H; Zhang M; Guo Y; Sun M Colloids Surf B Biointerfaces; 2019 Jan; 173():564-570. PubMed ID: 30347383 [TBL] [Abstract][Full Text] [Related]
16. Hypoxia Induced by Upconversion-Based Photodynamic Therapy: Towards Highly Effective Synergistic Bioreductive Therapy in Tumors. Liu Y; Liu Y; Bu W; Cheng C; Zuo C; Xiao Q; Sun Y; Ni D; Zhang C; Liu J; Shi J Angew Chem Int Ed Engl; 2015 Jul; 54(28):8105-9. PubMed ID: 26012928 [TBL] [Abstract][Full Text] [Related]
17. Silk fibroin-capped metal-organic framework for tumor-specific redox dyshomeostasis treatment synergized by deoxygenation-driven chemotherapy. Yu H; Li Y; Zhang Z; Ren J; Zhang L; Xu Z; Kang Y; Xue P Acta Biomater; 2022 Jan; 138():545-560. PubMed ID: 34775125 [TBL] [Abstract][Full Text] [Related]
18. Polydopamine-coated UiO-66 nanoparticles loaded with perfluorotributylamine/tirapazamine for hypoxia-activated osteosarcoma therapy. Chen H; Fu Y; Feng K; Zhou Y; Wang X; Huang H; Chen Y; Wang W; Xu Y; Tian H; Mao Y; Wang J; Zhang Z J Nanobiotechnology; 2021 Sep; 19(1):298. PubMed ID: 34592996 [TBL] [Abstract][Full Text] [Related]
19. Organosilica-Based Hollow Mesoporous Bilirubin Nanoparticles for Antioxidation-Activated Self-Protection and Tumor-Specific Deoxygenation-Driven Synergistic Therapy. Shan L; Fan W; Wang W; Tang W; Yang Z; Wang Z; Liu Y; Shen Z; Dai Y; Cheng S; Jacobson O; Zhai K; Hu J; Ma Y; Kiesewetter DO; Gao G; Chen X ACS Nano; 2019 Aug; 13(8):8903-8916. PubMed ID: 31374171 [TBL] [Abstract][Full Text] [Related]
20. Cancer cell membrane-coated C-TiO Ning S; Dai X; Tang W; Guo Q; Lyu M; Zhu D; Zhang W; Qian H; Yao X; Wang X Acta Biomater; 2022 Oct; 152():562-574. PubMed ID: 36067874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]